Moderna, Inc. Common Stock (MRNA) Financials
Key financial figures for Moderna, Inc. Common Stock (Q1 2026).
- Revenue
- $389M
- Net Income
- -$1.3B
- EPS
- $-3.40
- Total Assets
- $11.5B
- Operating Cash Flow
- -$630M
Full income statement, balance sheet, and cash flow for Moderna, Inc. Common Stock on SentiSense.